MiMedx Group Inc (MDXG)
6.245
-0.18
(-2.88%)
USD |
NASDAQ |
Apr 25, 16:00
6.245
0.00 (0.00%)
Pre-Market: 20:00
MiMedx Group Debt to Equity Ratio: 0.337 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
December 31, 2023 | 0.337 |
September 30, 2023 | 36.82 |
June 30, 2023 | -3.856 |
March 31, 2023 | -2.714 |
December 31, 2022 | -2.702 |
September 30, 2022 | -2.483 |
June 30, 2022 | -3.555 |
March 31, 2022 | -6.489 |
December 31, 2021 | 586.91 |
September 30, 2021 | -8.267 |
June 30, 2021 | -6.712 |
March 31, 2021 | -5.937 |
December 31, 2020 | -317.98 |
September 30, 2020 | 3.701 |
June 30, 2020 | 2.853 |
March 31, 2020 | 2.155 |
December 31, 2019 | 1.909 |
September 30, 2019 | 1.666 |
June 30, 2019 | 2.707 |
March 31, 2019 | 0.00 |
December 31, 2018 | 0.00 |
September 30, 2018 | |
June 30, 2018 | |
March 31, 2018 | |
December 31, 2017 | 0.00 |
Date | Value |
---|---|
September 30, 2017 | 0.00 |
June 30, 2017 | 0.00 |
March 31, 2017 | 0.00 |
December 31, 2016 | 0.00 |
September 30, 2016 | 0.00 |
June 30, 2016 | 0.00 |
March 31, 2016 | 0.00 |
December 31, 2015 | 0.00 |
September 30, 2015 | 0.00 |
June 30, 2015 | 0.00 |
March 31, 2015 | 0.00 |
December 31, 2014 | 0.00 |
September 30, 2014 | 0.00 |
June 30, 2014 | 0.00 |
March 31, 2014 | 0.00 |
December 31, 2013 | 0.00 |
September 30, 2013 | 0.00 |
June 30, 2013 | 0.00 |
March 31, 2013 | 0.00 |
December 31, 2012 | 0.2005 |
September 30, 2012 | 0.2433 |
June 30, 2012 | 0.3374 |
March 31, 2012 | 0.384 |
December 31, 2011 | 0.4345 |
September 30, 2011 | 0.198 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-317.98
Minimum
Dec 2020
586.91
Maximum
Dec 2021
14.65
Average
-2.483
Median
Sep 2022
Debt to Equity Ratio Benchmarks
TELA Bio Inc | 2.146 |
Amylyx Pharmaceuticals Inc | 0.00 |
CEL-SCI Corp | -- |
AIM ImmunoTech Inc | 0.00 |
IGC Pharma Inc | 0.0152 |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 239.05M |
Total Liabilities (Quarterly) | 96.33M |
Shareholders Equity (Quarterly) | 142.72M |
Current Ratio | 3.570 |
Net Debt Paydown Yield | 0.01% |